Literature DB >> 18450430

Early reduction in prefrontal theta QEEG cordance value predicts response to venlafaxine treatment in patients with resistant depressive disorder.

Martin Bares1, Martin Brunovsky, Miloslav Kopecek, Tomas Novak, Pavla Stopkova, Jiri Kozeny, Peter Sos, Vladimir Krajca, Cyril Höschl.   

Abstract

INTRODUCTION: Previous studies of patients with unipolar depression have shown that early decrease of prefrontal EEG cordance in theta band can predict clinical response to various antidepressants. We have now examined whether decrease of prefrontal quantitative EEG (QEEG) cordance value after 1 week of venlafaxine treatment predicts clinical response to venlafaxine in resistant patients.
METHOD: We analyzed 25 inpatients who finished 4-week venlafaxine treatment. EEG data were monitored at baseline and after 1 week of treatment. QEEG cordance was computed at three frontal electrodes in theta frequency band. Depressive symptoms and clinical status were assessed using Montgomery-Asberg Depression Rating Scale (MADRS), Beck Depression Inventory-Short Form (BDI-S) and Clinical Global Impression (CGI).
RESULTS: Eleven of 12 responders (reduction of MADRS >or=50%) and only 5 of 13 non-responders had decreased prefrontal QEEG cordance value after the first week of treatment (p=0.01). The decrease of prefrontal cordance after week 1 in responders was significant (p=0.03) and there was no significant change in non-responders. Positive and negative predictive values of cordance reduction for response were 0.7 and 0.9, respectively.
CONCLUSION: The reduction of prefrontal theta QEEG cordance value after first week of treatment might be helpful in the prediction of response to venlafaxine.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18450430     DOI: 10.1016/j.eurpsy.2008.03.001

Source DB:  PubMed          Journal:  Eur Psychiatry        ISSN: 0924-9338            Impact factor:   5.361


  26 in total

1.  Frontal theta cordance predicts 6-month antidepressant response to subcallosal cingulate deep brain stimulation for treatment-resistant depression: a pilot study.

Authors:  James M Broadway; Paul E Holtzheimer; Matthew R Hilimire; Nathan A Parks; Jordan E Devylder; Helen S Mayberg; Paul M Corballis
Journal:  Neuropsychopharmacology       Date:  2012-03-14       Impact factor: 7.853

2.  Role of Reward Sensitivity and Processing in Major Depressive and Bipolar Spectrum Disorders.

Authors:  Lauren B Alloy; Thomas Olino; Rachel D Freed; Robin Nusslock
Journal:  Behav Ther       Date:  2016-03-07

3.  The effectiveness of prefrontal theta cordance and early reduction of depressive symptoms in the prediction of antidepressant treatment outcome in patients with resistant depression: analysis of naturalistic data.

Authors:  Martin Bares; Tomas Novak; Miloslav Kopecek; Martin Brunovsky; Pavla Stopkova; Cyril Höschl
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-05-22       Impact factor: 5.270

4.  General and comparative efficacy and effectiveness of antidepressants in the acute treatment of depressive disorders: a report by the WPA section of pharmacopsychiatry.

Authors:  Thomas C Baghai; Pierre Blier; David S Baldwin; Michael Bauer; Guy M Goodwin; Kostas N Fountoulakis; Siegfried Kasper; Brian E Leonard; Ulrik F Malt; Dan Stein; Marcio Versiani; Hans-Jürgen Möller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2011-11       Impact factor: 5.270

Review 5.  Progress in Elucidating Biomarkers of Antidepressant Pharmacological Treatment Response: A Systematic Review and Meta-analysis of the Last 15 Years.

Authors:  G Voegeli; M L Cléry-Melin; N Ramoz; P Gorwood
Journal:  Drugs       Date:  2017-12       Impact factor: 9.546

6.  Resting-State Quantitative Electroencephalography Demonstrates Differential Connectivity in Adolescents with Major Depressive Disorder.

Authors:  Molly McVoy; Michelle E Aebi; Kenneth Loparo; Sarah Lytle; Alla Morris; Nicole Woods; Elizabeth Deyling; Curtis Tatsuoka; Farhad Kaffashi; Samden Lhatoo; Martha Sajatovic
Journal:  J Child Adolesc Psychopharmacol       Date:  2019-05-09       Impact factor: 2.576

7.  EEG power asymmetry and functional connectivity as a marker of treatment effectiveness in DBS surgery for depression.

Authors:  Maher A Quraan; Andrea B Protzner; Zafiris J Daskalakis; Peter Giacobbe; Chris W Tang; Sidney H Kennedy; Andres M Lozano; Mary P McAndrews
Journal:  Neuropsychopharmacology       Date:  2013-11-28       Impact factor: 7.853

8.  Electroencephalographic Biomarkers for Treatment Response Prediction in Major Depressive Illness: A Meta-Analysis.

Authors:  Alik S Widge; M Taha Bilge; Rebecca Montana; Weilynn Chang; Carolyn I Rodriguez; Thilo Deckersbach; Linda L Carpenter; Ned H Kalin; Charles B Nemeroff
Journal:  Am J Psychiatry       Date:  2018-10-03       Impact factor: 18.112

Review 9.  Biomarkers to predict antidepressant response.

Authors:  Andrew F Leuchter; Ian A Cook; Steven P Hamilton; Katherine L Narr; Arthur Toga; Aimee M Hunter; Kym Faull; Julian Whitelegge; Anne M Andrews; Joseph Loo; Baldwin Way; Stanley F Nelson; Steven Horvath; Barry D Lebowitz
Journal:  Curr Psychiatry Rep       Date:  2010-12       Impact factor: 5.285

10.  Antidepressant response trajectories and quantitative electroencephalography (QEEG) biomarkers in major depressive disorder.

Authors:  Aimee M Hunter; Bengt O Muthén; Ian A Cook; Andrew F Leuchter
Journal:  J Psychiatr Res       Date:  2009-07-24       Impact factor: 4.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.